- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07583615
Social Attention in ASD and TD Children
Dynamic Gaze Strategies in ASD Children During Social Interactions: An Eye-Tracking Investigation Under Intention-Congruent and -Incongruent Conditions
Descripción general del estudio
Estado
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Sichuan
-
Chengdu, Sichuan, Porcelana, 611731
- School of Foreign Languages, University of Electronic Science and Technology of China
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder. For TD group: Typically developing children without any developmental or neurological disorders.
Both groups: Normal or corrected-to-normal vision, no color vision deficiencies, and legal guardian provided written informed consent.
Exclusion Criteria:
- Failure to meet the study's group-specific screening cutoffs on the Social Responsiveness Scale (SRS) and Social Communication Questionnaire (SCQ) Known genetic syndromes, significant hearing loss, or uncorrectable visual impairment
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Autism Spectrum Disorder (ASD) Group
|
|
Typically Developing (TD) Group
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Percentage of Total Fixation Duration on Human Faces during Entire Video
Periodo de tiempo: During the full 27-second video presentation
|
Percentage of total fixation duration on human faces was calculated as (total fixation duration on all face areas of interest / total fixation duration on the entire video) × 100.
Fixation was defined as gaze maintained within a 1° visual angle for a minimum of 100 ms.
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Total Fixation Duration on Human Faces during Entire Video
Periodo de tiempo: During the full 27-second video presentation
|
Total fixation duration (in milliseconds) on human faces, calculated as the sum of all fixation durations that fell within face areas of interest (AOIs).
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Percentage of Total Fixation Duration on Human Faces During Phase 4 (Emotional Feedback) by Condition
Periodo de tiempo: During seconds 22-27 of the video
|
Percentage of fixation duration on faces was calculated for the emotional feedback phase separately for Preference-congruent and Preference-incongruent trials.
The interaction between Group (ASD vs. TD) and Condition (Congruent vs. Incongruent) was examined.
Higher percentages indicate greater allocation of visual attention to faces during emotional feedback.
|
During seconds 22-27 of the video
|
|
Total Scanpath Length During Entire Video
Periodo de tiempo: During the full 27-second video presentation
|
During the full 27-second video presentation
|
|
|
Number of Gaze Shifts Between Face and Object Areas of Interest
Periodo de tiempo: During the full 27-second video presentation
|
The number of saccadic gaze shifts that cross between pre-defined face and object areas of interest (AOIs) was counted.
This was taken as an index of attentional switching between social and non-social information.
|
During the full 27-second video presentation
|
|
Mean Distance of Fixation Points from the Center of the Face Area of Interest
Periodo de tiempo: During the full 27-second video presentation
|
For each fixation, the Euclidean distance (in degrees of visual angle) from its location to the centroid of the pre-defined face AOI was calculated.
The mean of these distances across all fixations was then computed.
Larger values indicate that gaze tended to fall farther from the faces, reflecting less attention to facial information.
|
During the full 27-second video presentation
|
Colaboradores e Investigadores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- UESTC-GazeLab-02
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .